6 trends tracked about this subject — the full history, oldest to newest below.
Gene therapy pioneer Sangamo Therapeutics files for bankruptcy, with Lilly and Astellas racing to acquire its assets
Pfizer’s experimental lung cancer drug sigvotatug vedotin has failed to meet its primary objective in a late-stage clinical trial.
AbbVie’s $10.9B bid for Apogee Therapeutics reshapes biotech M&A landscape overnight
Debate intensifies over U.S. and China biotech competition and domestic manufacturing reliance.
The Department of Health and Human Services has initiated a wide-ranging effort to accelerate clinical trials and reclaim American leadership in biotech.
AbbVie’s $10.9B bid for Apogee Therapeutics signals a high-stakes bet on next-gen autoimmune treatments—including a potential Dupixent rival.